Higher risk for gestational diabetes and some poor newborn outcomes reported, but lower risk for some adverse pregnancy ...

Phase 3 trial results demonstrate the superiority of long-acting injectable cabotegravir + rilpivirine over daily oral ...

The company revised its plan to seek full approval for middle-aged adults and accelerated approval for seniors.

We explore the FDA’s expansion of Wakix as the first non-scheduled treatment for pediatric cataplexy; a Taltz and Zepbound combo shows promise in skin clearance for patients with psoriasis and obesity ...

GLP-1 RAs linked to increased risk for androgenetic alopecia, nonscarring hair loss, telogen effluvium at 6 months.

HealthDay News — Capacitive-resistive monopolar radiofrequency significantly improved sexual function and vaginal health in women with genitourinary syndrome of menopause, according to a study ...

HealthDay News — Customers who recently bought frozen salmon at BJ’s Wholesale Club should check the packaging before their next meal. Wellesley Farms Farm-Raised Atlantic Salmon is being pulled from ...

Researchers reviewed the phase 3 findings of a TKI inhibitor treatment compared with aflibercept 2 mg for maintaining vision in patients with wet AMD.

The US Food and Drug Administration (FDA) has announced a recall of more than 20,000 peanut butter products after pieces of plastic were found during the manufacturing process.

HealthDay News — For women with functional hypothalamic amenorrhea (FHA), transdermal hormone replacement therapy (HRT) improves bone mineral density (BMD) at the lumbar spine (LS) and femoral neck ...

HealthDay News — A ketogenic diet (KD) may aid adults with treatment-resistant depression (TRD) in the short term, according to a study published online February 4 in JAMA Psychiatry.

Phase 3 results suggest intravenous vedolizumab is effective and safe for clinical remission in pediatric patients with moderate to severe UC.